KNOWLEDGE, ATTITUDE AND PRACTICE OF YEMENI PHYSICIANS TOWARD PHARMACOVIGILANCE: A MIXED METHOD STUDY

  • Yaser Mohammed Al-worafi College of Pharmacy, University of Science and Technology, Yemen College of Pharmacy, Ajman University, UAE

Abstract

Objective: The objective of the current study was to investigate the physician’s knowledge, attitude and practice towards pharmacovigilance.

Methods: A mixed qualitative and quantitative method was conducted in this study using a face to face questionnaire among the physicians in the capital Sana'a, Yemen.

Results: Of the 105 respondents (79 %) were male. Participants age mean was 35.55±4.45 y. Majority of physicians (73.3 %) had a moderate knowledge towards pharmacovigilance; (15.2 %) had a good knowledge and (11.4 %) had a poor knowledge. 35 (33.3 %) physicians were seen adverse drug reactions (ADRs) happened to their patients. Allergy was the most common ADRs. However, no ADR was reported. 66.7 % of physicians had a positive attitude towards pharmacovigilance. The most barriers reported by physicians were: lack of motivation and lack of knowledge about reporting system. Reported factors to encourage ADRs reporting were: attend courses or workshops; educational materials and simplification of reporting procedures.

Conclusion: Majority of physicians in Sana’a, Yemen had moderate knowledge and postitive attitude towards pharmacovigilance. Educational and training programmes are the cornerstone of improving ADRs reporting in Yemen. 

Keywords: Pharmacovigilance, Knowledge, Attitude, Physicians and Yemen

Downloads

Download data is not yet available.

References

1. WHO publications. The importance of pharmacovigilance: safety monitoring of medicinal products. WHO Collaborating Centre for International Drug Monitoring, Geneva, Switzerland; 2002.
2. World Health Organization. The safety of medicines in public health programmes: pharmacovigilance, an essential tool; 2006. Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf. [Last accessed on 10 Apr 2018]
3. Hazell L, Shakir SA. Under-reporting of adverse drug reactions. Drug safety 2006;29:385-96.
4. Härmark L, Van Grootheest AC. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol 2008;64:743-52.
5. World Health Organization. International drug monitoring: the role of national centres, report of a WHO meeting; 1971. Available from: http://apps.who.int/iris/handle/10665/40968. [Last accessed on 10 Apr 2018]
6. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. Br Med J 1998;316:1295–8.
7. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832–40.
8. Pirmohamed M, James S, Meakin S. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 2004;329:15–9.
9. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
10. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6.
11. Yemeni Pharmacovigilance Center (YPVC); 2014. Available from: http://www.ypvc-sbd.com. [Last accessed on 01 May 2014]
12. Al-Worafi YM. Comment on: pharmacovigilance in the middle East. Drug Safety 2014;37:651.
13. Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ, Green M, Andrews LG, et al. Physician reporting of adverse drug reactions. JAMA 1990;263:1785-8.
14. Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res 1997;35:85-8.
15. Ministry of Public Health and Population. Annual statistical health report; 2014. Available from: http://www.mophp-ye.org/arabic/ docs/Report2014.pdf. [Last accessed on 10 Apr 2018]
16. Pharmacovigilance guideline. World Health Organization. Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/S.AfricaDraftGuidelines.pdf. [Last accessed on 10 Apr 2018]
17. Al-Worafi YM, Kassab YW, Alseragi WM, Almutairi MS, Ahmed A, Ming LC, et al. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in sana’a, Yemen. Ther Clin Risk Management 2017;13:1175.
18. Van Grootheest AC, Mes K, De Jong-Van, Den Berg LTW. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Practice 2002;10:267-72.
19. Abdel-Latif MM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J 2015;23:154-61.
20. Iffat W, Shakeel S, Rahim N, Anjum F, Nesar S, Ghayas S. Pakistani physicians knowledge and attitude towards reporting adverse drug reactions. Afr J Pharm Pharmacol 2014;8:379-85.
21. Adedeji WA, Ibraheem WA, Fehintola FA. Attitude and practice of doctors toward adverse drug reactions (ADRs) reporting in a Nigerian tertiary health facility. Annals Ibadan Postgraduate Med 2013;11:77-80.
22. Lopez Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions. Drug Safety 2009;32:19-31.
23. Agarwal R, Daher AM, Ismail NM. Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from Klang Valley in Malaysia. Malaysian J Med Sci 2013;20:52.
24. AL-Worafi YM. Pharmacy practice in Yemen. In: Pharmacy Practice in Developing Countries: Achievements and Challenges; 2016. p. 267–87.
25. Raut AS, Pawar AT, Pankaj MA, Srivastava PR, Mishra AD. Clinical pattern and severity of cutaneous adverse drug reactions. Int J Pharm Pharm Sci 2013;5:612-6.
Statistics
103 Views | 247 Downloads
Citatons
How to Cite
Al-worafi, Y. M. “KNOWLEDGE, ATTITUDE AND PRACTICE OF YEMENI PHYSICIANS TOWARD PHARMACOVIGILANCE: A MIXED METHOD STUDY”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 10, no. 10, Oct. 2018, pp. 74-77, doi:10.22159/ijpps.2018v10i10.27407.
Section
Original Article(s)